NCT06620133 Pain Education and Patient-led Goal Setting in Adults With Chronic Low Back Pain: a Randomised Controlled Trial
| NCT ID | NCT06620133 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Neuroscience Research Australia |
| Condition | Chronic Low Back Pain (Non-specific, Uncomplicated) |
| Study Type | INTERVENTIONAL |
| Enrollment | 392 participants |
| Start Date | 2025-06-26 |
| Primary Completion | 2028-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 392 participants in total. It began in 2025-06-26 with a primary completion date of 2028-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goal of this clinical trial is to investigate the effectiveness of two treatments for adults with chronic low back pain. The main question this study seeks to answer is "In adults with chronic low back pain, what is the effectiveness of pain education and patient-led goal setting compared to guideline-based written advice on reducing pain intensity and disability?". A total of 392 participants will be randomised into two groups: 1) pain education and patient-led goal setting or 2) guideline-based written advice. Participants randomised to the pain education and patient-led goal setting group will receive 5 sessions of 45-60 min each over 8 weeks delivered online via telehealth. Participants randomised to written advice group will receive information developed for people with chronic low back pain. Outcomes will be assessed at baseline and week 8, 26 and 52.
Eligibility Criteria
Inclusion Criteria: * Low back pain of at least 3 months duration * physically inactive (less than or equal to 150min/week moderate intensity physical activity; 75 min/week vigorous activity, or some combination of the two) * no known contraindication(s) to performing physical activity * English language proficiency * access to internet Exclusion Criteria: * physically active (more than 150min/week moderate intensity physical activity, 75 min/week vigorous activity, or some combination of the two) * known contraindication(s) to performing physical activity * known or suspected serious spinal pathology (fracture, metastatic, inflammatory or infective diseases of the spine, cauda equina syndrome/widespread neurological disorder) * scheduled for major surgery during the treatment or follow-up period
Contact & Investigator
Matthew D Jones
PRINCIPAL INVESTIGATOR
UNSW Sydney
Frequently Asked Questions
Who can join the NCT06620133 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Chronic Low Back Pain (Non-specific, Uncomplicated). Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06620133 currently recruiting?
Yes, NCT06620133 is actively recruiting participants. Contact the research team at capacity@neura.edu.au for enrollment information.
Where is the NCT06620133 trial being conducted?
This trial is being conducted at Sydney, Australia.
Who is sponsoring the NCT06620133 clinical trial?
NCT06620133 is sponsored by Neuroscience Research Australia. The principal investigator is Matthew D Jones at UNSW Sydney. The trial plans to enroll 392 participants.